For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
4
views
3
references
 Top references
cited by
101
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      3,074
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy : A Randomized Clinical Trial

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ranibizumab is a viable treatment option for eyes with proliferative diabetic retinopathy (PDR) through 2 years. However, longer-term results are needed.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: not found
          • Article: not found

          Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

          (1994)
          Article 0 comments Cited 212 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A Novel Treatment for Proliferative Diabetic Retinopathy

            Adam R Glassman, Jeffrey G Gross (2016)
            Article 0 comments Cited 9 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy

              Jeffrey G Gross, Adam R Glassman, Margaret Klein … (2017)
              This Research Letter compares treatment with intraviterous ranibizumab with undergoing panretinal photocoagulation for managing proliferative diabetic retinopathy.
              Article 0 comments Cited 5 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Title: JAMA Ophthalmology
                Abbreviated Title: JAMA Ophthalmol
                Publisher: American Medical Association (AMA)
                ISSN (Print): 2168-6165
                Publication date Created: October 01 2018
                Publication date (Print): October 01 2018
                Volume: 136
                Issue: 10
                Page: 1138
                Affiliations
                [1 ]Carolina Retina Center PA, Columbia, South Carolina
                [2 ]Jaeb Center for Health Research, Tampa, Florida
                [3 ]Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts
                [4 ]CME Editor, JAMA Ophthalmology
                [5 ]Charlotte Eye, Ear, Nose and Throat Associates, PA, Charlotte, North Carolina
                [6 ]Paducah Retinal Center, Paducah, Kentucky
                [7 ]Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
                [8 ]Editor, JAMA Ophthalmology
                [9 ]Elman Retina Group, PA, Baltimore, Maryland
                [10 ]Ophthalmic Research Consultants, LLC, Waxhaw, North Carolina
                [11 ]Deputy Editor, Opinion, JAMA Ophthalmology
                [12 ]Kellogg Eye Center, University of Michigan, Ann Arbor
                [13 ]Feinberg School of Medicine, Northwestern University, Chicago, Illinois
                [14 ]Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
                [15 ]Deputy Editor, JAMA Ophthalmology
                Article
                DOI: 10.1001/jamaophthalmol.2018.3255
                PMC ID: 6233839
                PubMed ID: 30043039
                SO-VID: 090ea05b-0756-4b8a-b7d8-7a797ebc7b8a
                Copyright © © 2018
                History

                Data availability:

                Comments

                Comment on this article

                scite_

                Similar content3,074

                See all similar

                Cited by118

                See all cited by

                Most referenced authors320

                See all reference authors